These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 10693867)

  • 1. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
    Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
    Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
    de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; Fiselier TJ; Franssen MJ; Joosten LA; Van Lent PL; Richards CD; van den Berg WB
    Arthritis Rheum; 2003 Jun; 48(6):1750-61. PubMed ID: 12794844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
    Hui W; Rowan AD; Richards CD; Cawston TE
    Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical significance of cytokine determination in joint fluid in patients with arthroses or rheumatoid arthritis].
    Neidel J; Schulze M; Sova L; Lindschau J
    Z Orthop Ihre Grenzgeb; 1996; 134(4):381-5. PubMed ID: 8928570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.
    Taniguchi N; Kawahara K; Yone K; Hashiguchi T; Yamakuchi M; Goto M; Inoue K; Yamada S; Ijiri K; Matsunaga S; Nakajima T; Komiya S; Maruyama I
    Arthritis Rheum; 2003 Apr; 48(4):971-81. PubMed ID: 12687539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
    Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
    Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
    Bell MC; Carroll GJ
    J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.
    Poole AR; Ionescu M; Swan A; Dieppe PA
    J Clin Invest; 1994 Jul; 94(1):25-33. PubMed ID: 7518830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
    Danning CL; Illei GG; Hitchon C; Greer MR; Boumpas DT; McInnes IB
    Arthritis Rheum; 2000 Jun; 43(6):1244-56. PubMed ID: 10857783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.